Report of three imported cases of neurocysticercosis in Guadeloupe

被引：2

作者：

Blaizot, R. ^{[1
,2
]}

Melot, B. ^{[1
,2
]}

Schepers, K. ^{[1
,2
]}

Nicolas, M. ^{[3
]}

Gaumond, S. ^{[4
]}

Poullain, P. ^{[5
]}

Belaye, L. ^{[5
]}

Lannuzel, A. ^{[6
,7
,8
]}

Hoen, B. ^{[1
,2
,7
]}

机构：

[1] Ctr Hosp Univ Pointe A Pitre, Serv Malad Infect & Trop, Pointe a Pitre, France

[2] Ctr Hosp Univ Pointe A Pitre, Inserm CIC 1424, Pointe a Pitre, France

[3] Ctr Hosp Univ Pointe A Pitre, Lab Microbiol Clin & Environm, Pointe a Pitre, France

[4] Ctr Hosp Univ Pointe A Pitre, Serv Anat Pathol, Pointe a Pitre, France

[5] Ctr Hosp Univ Pointe A Pitre, Serv Radiol, Pointe a Pitre, France

[6] Ctr Hosp Univ Pointe A Pitre, Serv Neurol, Pointe a Pitre, France

[7] Univ Antilles, Fac Med Antilles Guyane, EA 4537, Pointe a Pitre, Guadeloupe, France

[8] UPMC Univ Paris 06, Sorbonne Univ, INSERM, CNRS,UM 75,U1127,ICM, F-75013 Paris, France

来源：

BMC INFECTIOUS DISEASES | 2017年 / 17卷

关键词：

Neurocysticercosis; Prevention and control; Emerging diseases; Epidemiology; Case reports; TAENIA-SOLIUM CYSTICERCOSIS; CEREBROVASCULAR COMPLICATIONS; DIAGNOSTIC-CRITERIA; SEIZURE RECURRENCE; ALBENDAZOLE; SEROPREVALENCE; PREVALENCE; EFFICACY;

D O I：

10.1186/s12879-016-2169-8

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Background: Neurocysticercosis is endemic in most countries of Central and South America but has rarely been described in the French West Indies. We aimed to better understand the clinical and radiological presentation of our cases. Case presentation: We report three cases of neurocysticercosis in patients living in Guadeloupe, with different clinical and radiological presentations. Conclusion: Given the eventuality of autochtonous transmission, the diagnosis should be considered in all patients living in Guadeloupe presenting with seizures.

引用

页数：7

共 37 条

[1] IMMUNODIAGNOSIS OF TAENIASIS BY COPROANTIGEN DETECTION [J].

ALLAN, JC ;

AVILA, G ;

NOVAL, JG ;

FLISSER, A ;

CRAIG, PS .

PARASITOLOGY, 1990, 101 :473-477

[2] Evidence-based guideline: Treatment of parenchymal neurocysticercosis Report of the Guideline Development Subcommittee of the American Academy of Neurology [J].

Baird, Ruth Ann ;

Wiebe, Sam ;

Zunt, Joseph R. ;

Halperin, John J. ;

Gronseth, Gary ;

Roos, Karen L. .

NEUROLOGY, 2013, 80 (15) :1424-1429

[3]

Brutto OHD, 2013, CYSTICERCOSIS HUMAN

[4] Cerebrovascular complications of neurocysticercosis - Clinical and neuroimaging spectrum [J].

Cantu, C ;

Barinagarrementeria, F .

ARCHIVES OF NEUROLOGY, 1996, 53 (03) :233-239

[5]

CaparrosLefebvre D, 1997, PRESSE MED, V26, P1574

[6] Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial [J].

Carpio, A. ;

Kelvin, E. A. ;

Bagiella, E. ;

Leslie, D. ;

Leon, P. ;

Andrews, H. ;

Hauser, W. A. .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (09) :1050-1055

[7] Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis [J].

Carpio, A ;

Hauser, WA .

NEUROLOGY, 2002, 59 (11) :1730-1734

[8] MRI of CNS parasitic diseases [J].

Chang, KH ;

Han, MH .

JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1998, 8 (02) :297-307

[9] Proposed diagnostic criteria for neurocysticercosis [J].

Del Brutto, OH ;

Rajshekhar, V ;

White, AC ;

Tsang, VCW ;

Nash, TE ;

Takayanagui, OM ;

Schantz, PM ;

Evans, CAW ;

Flisser, A ;

Correa, D ;

Botero, D ;

Allan, JC ;

Sarti, E ;

Gonzalez, AE ;

Gilman, RH ;

García, HH .

NEUROLOGY, 2001, 57 (02) :177-183

[10]

Del Brutto OH, 2012, INFECT DIS, V18, P1392

← 1 2 3 4 →